RNA drugs are a new type of medicine that treat disease by influencing how cells use genetic information, rather than by ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Have you ever wondered what separates a good design from a truly exceptional one? Often, it’s not just the creativity of the designer but their mastery of the tools at their disposal. Enter Affinity 3 ...

The global plasmid DNA manufacturing market size is valued at USD 2.68 billion in 2025 and is predicted to increase from USD 3.25 billion in 2026 to reach around USD 18.11 billion by 2034, registering ...

Eli Lilly (LLY) has reached a research and licensing agreement worth up to $1.2B with SanegeneBio to develop and commercialize RNAi therapeutics for metabolic diseases, the Boston, Massachusetts-based ...

Creative suite company Canva launched its own design model on Thursday that understands design layers and formats to power its features. The company also introduced new products and features, updates ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Targovax ASA ( (GB:0RIS)) has shared an ...

The vector consists of a polyethylene glycolylated liposomal outer coat (providing immune evasion and prolonged circulation), a spindle-shaped nanomotor (resembling a flagellum, facilitating targeted ...

Using artificial intelligence, researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. (Nanowerk News) Using ...

Vector-Based RNAi (RNA interference) is a technique that utilizes viral or plasmid vectors to deliver small interfering RNA (siRNA) molecules into target cells, facilitating gene silencing. This ...